Herpes Vaccine Candidates in 2026: Progress and Prospects
As we enter 2026, the global effort to develop an effective herpes simplex virus (HSV) vaccine has reached a critical turning point. The landscape was...
Read More5 articles tagged with this topic
As we enter 2026, the global effort to develop an effective herpes simplex virus (HSV) vaccine has reached a critical turning point. The landscape was...
Read More
Herpes simplex virus (HSV) infections caused by HSV-1 and HSV-2 affect approximately 3.7 billion people globally (roughly 67% for HSV-1 and 11% for HSV-2),...
Read More
Herpes simplex virus (HSV) infections caused by HSV-1 and HSV-2 affect a significant portion of the global population, causing recurrent painful symptoms and...
Read More
Editorial note: This article was written in 2025 and covers HSV vaccine candidates as they stood at that time. Vaccine research moves quickly — for the most...
Read More
This article covers the state of herpes research as of early 2025. For the most up-to-date overview of vaccine candidates and clinical trial progress, see our...
Read More